Abbott Reports First-Quarter 2023 Results; Increases Outlook For Underlying Base Business

Sales of $9.7 billion driven by strong underlying base business performance Reported sales decreased 18.1 percent due to anticipated decline in COVID-19 testing-related sales versus prior year Organic sales growth for underlying base business of 10.0 percent, led by Medical Devices,…